NIP
IDYA icon

Nicholas Investment Partners’s IDEAYA Biosciences IDYA Stock Holding History

Nicholas Investment Partners’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-248,202
Closed -$8.27M – 221
2026
Q1 		$8.27M Buy
248,202
+55,789
+29% +$1.87M 0.6% 61
2025
Q4 		$6.65M Buy
+192,413
New +$6.13M 0.48% 77
2024
Q4 		– Sell
-29,625
Closed -$939K – 233
2024
Q3 		$939K Sell
29,625
-41,411
-58% -$1.57M 0.09% 187
2024
Q2 		$2.49M Sell
71,036
-84,784
-54% -$3.36M 0.26% 132
2024
Q1 		$6.84M Buy
155,820
+45,469
+41% +$1.96M 0.7% 44
2023
Q4 		$3.93M Buy
+110,351
New +$3.29M 0.46% 80

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Nicholas Investment Partners's IDYA Position: Q2 2026 in Review

Nicholas Investment Partners sold out of IDEAYA Biosciences (IDYA) in Q2 2026, closing a stake of 248,202 shares — an estimated $8.27M sold.

Nicholas Investment Partners first reported a position in IDYA in Q4 2023 and held it in 6 quarters. The position peaked at $8.27M in Q1 2026. 284 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Nicholas Investment Partners reported no remaining IDEAYA Biosciences position as of Q2 2026 after selling out during the quarter.
  • Nicholas Investment Partners sold 248,202 IDEAYA Biosciences shares in Q2 2026, an estimated $8.27M.
  • Nicholas Investment Partners first reported a position in IDEAYA Biosciences in Q4 2023 and held it in 6 quarters.
  • Nicholas Investment Partners's IDEAYA Biosciences position peaked at $8.27M in Q1 2026.
  • 284 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Nicholas Investment Partners's 13F filing for Q2 2026, filed 14 Aug 2026.